Cite
MLA Citation
Ira J Dunkel et al.. “IMMU-08. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: efficacy, safety, biomarker, and pharmacokinetic results from Checkmate 908.” Neuro-oncology, vol. 24, n.d., pp. i82–i83. http://access.bl.uk/ark:/81055/vdc_100156448221.0x00002b